The Predictive Value of Myeloperoxidase for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction

References

• Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936. doi:10.1053/ajkd.2002.32766
   PubMed Web of Science ®Google Scholar
• James MT, Ghali WA, Tonelli M, et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int. 2010;78(8):803–809. doi:10.1038/ki.2010.258
   PubMed Web of Science ®Google Scholar
• Shaker OG, El-Shehaby A, El-Khatib M. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology. 2010;61(8):731–736. doi:10.1177/0003319710373093
   PubMed Web of Science ®Google Scholar
• Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005;25(6):1102–1111. doi:10.1161/01.ATV.0000163262.83456.6d
   PubMed Web of Science ®Google Scholar
• Abu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem. 2000;275(48):37524–37532. doi:10.1074/jbc.275.48.37524
   PubMed Web of Science ®Google Scholar
• Vita JA, Brennan ML, Gokce N, et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation. 2004;110(9):1134–1139. doi:10.1161/01.CIR.0000140262.20831.8F
   PubMed Web of Science ®Google Scholar
• Delporte C, Van Antwerpen P, Vanhamme L, Roumeguere T, Zouaoui Boudjeltia K. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm. 2013;2013:971579. doi:10.1155/2013/971579
   PubMed Web of Science ®Google Scholar
• Mocatta TJ, Pilbrow AP, Cameron VA, et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol. 2007;49(20):1993–2000. doi:10.1016/j.jacc.2007.02.040
   PubMed Web of Science ®Google Scholar
• Yunoki K, Naruko T, Komatsu R, et al. Relation of elevated levels of plasma myeloperoxidase to impaired myocardial microcirculation after reperfusion in patients with acute myocardial infarction. Am J Cardiol. 2010;105(7):922–929. doi:10.1016/j.amjcard.2009.11.013
   PubMed Web of Science ®Google Scholar
• Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003;349(17):1595–1604. doi:10.1056/NEJMoa035003
   PubMed Web of Science ®Google Scholar
• Hoy A, Leininger-Muller B, Kutter D, Siest G, Visvikis S. Growing significance of myeloperoxidase in non-infectious diseases. Clin Chem Lab Med. 2002;40(1):2–8. doi:10.1515/CCLM.2002.002
   PubMed Web of Science ®Google Scholar
• Yap YW, Whiteman M, Cheung NS. Chlorinative stress: an under appreciated mediator of neurodegeneration? Cell Signal. 2007;19(2):219–228. doi:10.1016/j.cellsig.2006.06.013
   PubMed Web of Science ®Google Scholar
• Kettle AJ, Chan T, Osberg I, et al. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med. 2004;170(12):1317–1323. doi:10.1164/rccm.200311-1516OC
   PubMed Web of Science ®Google Scholar
• Van Der Vliet A, Nguyen MN, Shigenaga MK, Eiserich JP, Marelich GP, Cross CE. Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol. 2000;279(3):L537–546. doi:10.1152/ajplung.2000.279.3.L537
   PubMed Web of Science ®Google Scholar
• Atwal M, Lishman EL, Austin CA, Cowell IG. Myeloperoxidase enhances etoposide and mitoxantrone-mediated DNA damage: a target for myeloprotection in cancer chemotherapy. Mol Pharmacol. 2017;91(1):49–57. doi:10.1124/mol.116.106054
   PubMedGoogle Scholar
• Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009;2009:137072. doi:10.1155/2009/137072
   PubMed Web of Science ®Google Scholar
• China Society of Cardiology of Chinese Medical Association EBoCJoC, China Society of Cardiology of Chinese Medical Association Editorial Board of Chinese Journal of C. [Guideline on the diagnosis and therapy of ST-segment elevation myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi. 2015;43(5):380–393. Chinese.
   PubMedGoogle Scholar
• Chinese Society of Cardiology of Chinese Medical A, Editorial Board of Chinese Journal of C. [Guideline of non-ST segment elevation acute coronary syndrome]. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40(5):353–367. Chinese.
   PubMedGoogle Scholar
• Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21(12):2527–2541. doi:10.1007/s00330-011-2225-0
   PubMed Web of Science ®Google Scholar
• Tsai TT, Patel UD, Chang TI, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1–9. doi:10.1016/j.jcin.2013.06.016
   PubMed Web of Science ®Google Scholar
• Narula A, Mehran R, Weisz G, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014;35(23):1533–1540. doi:10.1093/eurheartj/ehu063
   PubMed Web of Science ®Google Scholar
• Pisani A, Riccio E, Andreucci M, et al. Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy. Biomed Res Int. 2013;2013:868321. doi:10.1155/2013/868321
   PubMed Web of Science ®Google Scholar
• Andreucci M, Faga T, Pisani A, Sabbatini M, Michael A. Acute kidney injury by radiographic contrast media: pathogenesis and prevention. Biomed Res Int. 2014;2014:362725.
   PubMed Web of Science ®Google Scholar
• Azzalini L, Spagnoli V, Ly HQ. Contrast-induced nephropathy: from pathophysiology to preventive strategies. Can J Cardiol. 2016;32(2):247–255. doi:10.1016/j.cjca.2015.05.013
   PubMed Web of Science ®Google Scholar
• Kurtul A, Ornek E. Platelet to lymphocyte ratio in cardiovascular diseases: a systematic review. Angiology. 2019;70(9):802–818. doi:10.1177/0003319719845186
   PubMed Web of Science ®Google Scholar
• Kisic B, Miric D, Dragojevic I, Rasic J, Popovic L. Role of myeloperoxidase in patients with chronic kidney disease. Oxid Med Cell Longev. 2016;2016:1069743. doi:10.1155/2016/1069743
   PubMed Web of Science ®Google Scholar
• Hazen SL, Zhang R, Shen Z, et al. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res. 1999;85(10):950–958. doi:10.1161/01.RES.85.10.950
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ. New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest. 1987;79(5):1379–1387. doi:10.1172/JCI112965
   PubMed Web of Science ®Google Scholar
• Malle E, Buch T, Grone HJ. Myeloperoxidase in kidney disease. Kidney Int. 2003;64(6):1956–1967. doi:10.1046/j.1523-1755.2003.00336.x
   PubMed Web of Science ®Google Scholar
• Himmelfarb J. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial. 2009;22(6):636–643. doi:10.1111/j.1525-139X.2009.00659.x
   PubMed Web of Science ®Google Scholar
• Lin KY, Zheng WP, Bei WJ, et al. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention. Int J Cardiol. 2017;230:402–412. doi:10.1016/j.ijcard.2016.12.095
   PubMed Web of Science ®Google Scholar
• Yin WJ, Yi YH, Guan XF, et al. Preprocedural prediction model for contrast-induced nephropathy patients. J Am Heart Assoc. 2017;6(2). doi:10.1161/JAHA.116.004498
   Web of Science ®Google Scholar
• Yamamoto Y, Yamamoto N, Kanematsu Y, et al. High white blood cell count is a risk factor for contrast-induced nephropathy following mechanical thrombectomy for acute ischemic stroke. Cerebrovasc Dis Extra. 2020;10(2):59–65. doi:10.1159/000507918
   PubMed Web of Science ®Google Scholar
• Yuan Y, Qiu H, Hu X, et al. Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention. Clin Cardiol. 2017;40(9):719–725. doi:10.1002/clc.22722
   PubMed Web of Science ®Google Scholar
• Klein SJ, Brandtner AK, Lehner GF, et al. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2018;44(3):323–336. doi:10.1007/s00134-018-5126-8
   PubMed Web of Science ®Google Scholar